John A. Stalfort III

Insider Reports History

Location
Charlottesville, VA
Signature
/s/ Derek Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Stalfort III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. Director Common Stock 1.87M $4.61M $2.46 26 Nov 2024 Direct
Taysha Gene Therapies, Inc. Director Common Stock 1.16M $3.47M $3.00 02 Jun 2025 Direct
Taysha Gene Therapies, Inc. Director Common Stock 884K $2.65M $3.00 02 Jun 2025 Indirect
Acumen Pharmaceuticals, Inc. Director Common Stock 185K $204K $1.10 04 Jun 2025 Direct
Verrica Pharmaceuticals Inc. Director Series A Warrants (right to buy) 562K 22 Nov 2024 Direct
Verrica Pharmaceuticals Inc. Director Series B Warrants (right to buy) 562K 22 Nov 2024 Direct
Taysha Gene Therapies, Inc. Director Stock Option (right to buy) 113K 02 Jun 2025 Direct
Acumen Pharmaceuticals, Inc. Director Stock Option (right to buy) 19.5K 04 Jun 2025 Direct

Insider Reports Filed by John A. Stalfort III

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABOS Acumen Pharmaceuticals, Inc. 04 Jun 2025 2 $0 4 Director 05 Jun 2025, 16:59
TSHA Taysha Gene Therapies, Inc. 02 Jun 2025 2 $0 4 Director 04 Jun 2025, 16:15
VRCA Verrica Pharmaceuticals Inc. 22 Nov 2024 4 $0 4 Director 26 Nov 2024, 16:15
ABOS Acumen Pharmaceuticals, Inc. 10 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:49
TSHA Taysha Gene Therapies, Inc. 29 May 2024 2 $0 4 Director 31 May 2024, 16:18
TSHA Taysha Gene Therapies, Inc. 16 Aug 2023 3 $700K 4 Director 16 Aug 2023, 21:53
TSHA Taysha Gene Therapies, Inc. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 16:48
TSHA Taysha Gene Therapies, Inc. 22 Jun 2023 0 $0 3 Director 26 Jun 2023, 16:46
ABOS Acumen Pharmaceuticals, Inc. 06 Jun 2023 1 $0 4 Director 07 Jun 2023, 17:45
VRCA Verrica Pharmaceuticals Inc. 05 Jul 2022 1 $500K 4 Director 05 Jul 2022, 16:11
ABOS Acumen Pharmaceuticals, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:24
ABOS Acumen Pharmaceuticals, Inc. 06 Jul 2021 5 $560K 4 Director 08 Jul 2021, 18:17
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 0 $0 3/A Director 08 Jul 2021, 17:59
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 16:20